Vol.

30, N

o 2

(S3)

Apr

il - J

une,

201

6Jo

urna

l of B

iolo

gica

l Reg

ulat

ors &

Hom

eost

atic

Age

nts

Published byBiolife

ISSN 0393-974X/2016

Gio

vann

i Ant

onio

Can

al (d

etto

Can

alet

to),

Rega

ta su

l Can

al G

rand

e, 1

732

www.biolifesas.org

Volume 30, No 2 (S3), April - June,, 2016

JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTSVolume 30, No. 2 (Supplement 3), April - June, 2016

CONTENTS

1

9

15

21

29

35

43

49

55

65

73

77

83

89

95

103

109

115

121

129

U. Wollina, J. Hercogovấ, M. Fioranelli, S. Gianfaldoni, A.A. Chokoeva, G. Tchernev, M. Tirant, F. Novotny, M.G. Roccia, G.K. Maximov, K. França and T. Lotti. A multi-centred open trial of “Dr Michaels®” (also branded as Soratinex®) topical product family in psoriasis ......................................................

K. França, J. Hercogovấ, M. Fioranelli, S. Gianfaldoni, A.A. Chokoeva, G. Tchernev, U. Wollina, M. Tirant, F. Novotny, M.G. Roccia, G.K. Maximov and T. Lotti. A European prospective, randomized placebo-controlled double-blind study on the efficacy and safety of Dr Michaels® (also branded as Soratinex®) product family for stable chronic plaque psoriasis .............................. ...................................................... ...................................................... .......................................................

J. Hercogovấ, M. Fioranelli, S. Gianfaldoni, A.A. Chokoeva, G. Tchernev, U. Wollina, M. Tirant, F. Novotny, M.G. Roccia, G.K. Maximov, K. França and T. Lotti. A clinical examination of the efficacy of preparation of Dr Michaels® (also branded as Soratinex®) products in the treatment of asis .........

M. Tirant, J. Hercogovấ, M. Fioranelli, S. Gianfaldoni, A.A. Chokoeva, G. Tchernev, U. Wollina, F. Novotny, M.G. Roccia, G.K. Maximov, K. França and T. Lotti. Nail psoriasis in an adult successfully treated with a series of herbal skin care products family – a case report ........................................................

M. Fioranelli, J. Hercogovấ, S. Gianfaldoni, A.A.Chokoeva, G. Tchernev, U. Wollina, M Tirant, F. Novotny, M.G. Roccia, G.K. Maximov, K. França and T. Lotti. Clinical evaluation of the effectiveness of “Dr Michaels®” (also branded as Soratinex®) products in the topical treatment of patients with plaque psoriasis

M. Tirant, P. Anderson, P. Bayer, J. Hercogovấ, M. Fioranelli, S. Gianfaldoni, A.A. Chokoeva, G. Tchernev, U. Wollina, F. Novotny, M.G. Roccia, G.K. Maximov, K. França and T. Lotti. Successful treatment of a chronic eczema in a 48-year-old female with Dr Michaels® (Eczitinex® and Itchinex®) product family. a case report ........................................................................................................................................................................................ ....................................................................................

J. Hercogovấ, M. Fioranelli, S.Gianfaldoni, A.A. Chokoeva, G. Tchernev, U. Wollina, M Tirant, F.Novotny, M.G.Roccia, G.K. Maximov, K. França and T. Lotti. Dr Michaels® (Soratinex®) product for the topical treatment of psoriasis: a Hungarian/Czech and Slovak study ..................................................................

U. Wollina, M. Tirant, P. Bayer, M. Coburn, M. Smith, B. Donnelly, T. Kennedy, J. Gaibor, M. Arora, L. Clews, S. Walsley, J. Hercogovấ, M. Fioranelli, S. Gianfaldoni, A.A. Chokoeva, G. Tchernev, F.Novotny, M.G. Roccia, G.K. Maximov, K. França and T. Lotti. Successful treatment of mild to moderate acne vulgaris with Dr Michaels® (also branded as Zitinex®) topical products family: a clinical trial ................................................................................

K. França, J. Hercogovấ, M. Fioranelli, S. Gianfaldoni, A.A. Chokoeva, G. Tchernev, U. Wollina, M. Tirant, P. Bayer, M. Coburn, M. Smith, B. Donnelly, T. Kennedy, J. Gaibor, M. Arora, L. Clews, F. Novotny, M.G. Roccia, G.K. Maximov and T. Lotti. Investigation of the efficacy and tolerability of Dr Michaels® (also branded as Eczitinex® and Itchinex) topical products in the treatment of atopic dermatitis in children ..........................

M. Tirant, P. Bayer, J. Hercogovấ, M. Fioranelli, S.Gianfaldoni, A.A.Chokoeva, G. Tchernev, U. Wollina, F. Novotny, M.G. Roccia, G.K. Maximov, K. França and T. Lotti. Treatment of ichthyosis lamellaris using a series of herbal skin care products family ....................................................................................................

J. Hercogovấ, M. Fioranelli, S. Gianfaldoni, A.A. Chokoeva, G. Tchernev, U. Wollina, M. Tirant, F. Novotny, M.G. Roccia, G.K. Maximov, K. França and T. Lotti. Investigation of the efficacy of Dr Michaels® (Soratinex®) family in maintaining a symptom-free state for patients with psoriasis in remission. A retrospective, comparative study ...................................................................................................................................................................................................................................

J. Hercogovấ, M. Fioranelli, S. Gianfaldoni, A.A. Chokoeva, G. Tchernev, U. Wollina, M Tirant, F.Novotny, M.G.Roccia, G.K. Maximov, K. França, and T. Lotti. Dr Michaels® product family (also branded as Soratinex®) versus methylprednisolone aceponate - a comparative study of the effectiveness for the treatment of plaque psoriasis ........................................................................................................................................................................................ ...........................................................................

U. Wollina, J. Hercogovấ, M. Fioranelli, S.Gianfaldoni, A.A. Chokoeva, G. Tchernev, M. Tirant, F.Novotny, M.G. Roccia, G.K. Maximov, K. França and T. Lotti. Successful treatment of alopecia areata with Dr. Michaels® product family ...........................................................................................................................................

J. Hercogova, M. Tirant, P. Bayer, M. Coburn, B. Donnelly, T. Kennedy, J. Gaibor, M. Arora, L. Clews, M. Fioranelli, S. Gianfaldoni, A.A. Chokoeva, G. Tchernev, U.Wollina, F. Novotny, M.G. Roccia, G.K. Maximov, K. França and T. Lotti. Successful treatment of recalcitrant candidal intertrigo with Dr Michaels® (Fungatinex®) product family .........................................................................................................................................................................................................................................

M. Tirant, P. Bayer, J. Hercogovấ, M. Fioranelli, S. Gianfaldoni, A.A. Chokoeva, G. Tchernev, U. Wollina, F. Novotny, M.G.Roccia, G.K. Maximov, K. França and T. Lotti. Successful treatment of facial systemic lupus erythematosus lesions with Dr Michaels® (Soratinex®) product family. A case report

U. Wollina, J. Hercogovấ, M. Fioranelli, S. Gianfaldoni, A.A. Chokoeva, G. Tchernev, M. Tirant, F. Novotny, M.G. Roccia, G.K. Maximov, K. França and T. Lotti. Scalp psoriasis: a promising natural treatment ........................................................................................................................................................................................

S. Gianfaldoni, J. Hercogovấ, M. Fioranelli, A.A. Chokoeva, G. Tchernev, U.Wollina, M. Tirant, F. Novotny, M.G. Roccia, G.K. Maximov, K. França and T. Lotti. An innovative, promising topical treatment for psoriasis: a Romanian clinical study ............................................................................................................................

K. França, F. Novotny, J. Hercogovấ, M. Fioranelli, S.Gianfaldoni, A.A. Chokoeva, G. Tchernev, U. Wollina, M. Tirant, M.G. Roccia and T. Lotti. Efficacy and safety of Dr Michaels® (Soratinex®) product family for the topical treatment of psoriasis: a monitored status study .....................................................

K. França, M. Tirant, J. Hercogovấ, F. Novotny, M. Fioranelli, S. Gianfaldoni, A.A.Chokoeva, G. Tchernev, U.Wollina, M.G. Roccia and T. Lotti. Quality of life aspects of patients with psoriasis using a series of herbal products .....................................................................................................................................................................

V. Barygina, M. Becatti, A. Mannucci, N. Taddei, M. Tirant, J. Hercogova, K. França, M. Fioranelli, M.G. Roccia, G. Tchernev, U. Wollina, T. Lotti and C. Fiorillo. Short Comunication: a vegetable oil extract restores redox status in fibroblasts from psoriatic patients ................................................................................

SUPPLEMENTNEW, SAFE AND EFFECTIVE NATURAL PRODUCTS

FOR COMMON DERMATOLOGIC CONDITIONS

F. Carinci

JBRHA is published every 3 months by BIOLIFE, s.a.s.©. The annual subscription rate is: Institutional (all countries) Euro 390.00; personal Euro 290.00. Back issues available at Euro 220.00 for Institutional and Euro 190.00 for personal copy. Subscription only for P.R.China Euro 100.00. Payment may be in the form of money order or personal cheque made out to “Biolife, s.a.a.” or bank remittance to Banca Popolare Dell’Adriatico, Via Chieti, 65100 Pescara, Italy, account no. c/c 07400101024 (ABI 5748; CAB 1500) BIOLIFE, s.a.s. (IBAN: IT Y 05748 151000 7400101024E) or Visa/Mastercard. Information concerning personal subscription rates, business matters, advertisements and back numbers should be sen to: Biolife, s.a.s. Via S. Stefano, 39 bis, 64029 Silvi Marina (TE), Italy.Manuscripts should be sent to the Editor-ic-Chief: Dr. Pio Conti, Professor of Immunology, Postgraduate Medical School, University Zone, viale Unità d’Italia 73, 66100, Chieti, Italy. Tel/Fax.: +39 0871 574136; e-mail: piocontieditor@yahoo.it or biolife_sas@yahoo.it Website: www.biolifesas.orgChieti, Italy. Tel.: +39 0871/3554805 - Fax: +39 0871/3554804. U-mail: pioconti@unich.it Website: www.biolifesas.org Biolife sas e-mail: biolife_sas@yahoo.itCopyright © 2016 by BIOLIFE, s,a,s, This publication and/or article is for individual use only and may not be further reproduced without written permission from the copyright holder. Unauthorized reproduction may result in financial and other penalties.Authorization no. 304 of 07/06/1986 registered at the Court of Milan (Tribunale di Milano)Cited in: Current Contents, Clinical Medicine, Index Medicus/Mediline, Excerpta Medica, Embase/Chemical Abstracts Service, Scopus This Journal is printed on acid-free paper

INSTRUCTIONS FOR CONTRIBUTORS

Journal of Biological Regulators & Homeostatic Agents is a peer reviewed journal published every threemonths. The journal publishes original papers describing research in the fields of experimental and clinical medicine, molecular biology, biochemistry, regulatory molecules, cellular immunology and pharmacology. Only articles written in English will be published. All articles will be subject to peer review and the scientific standard is the only criterion for accepting a manuscript for publication. The style should be clear and concise. Excessive use of jargon or unusual abbreviations should be avoided. Contributors must send an electronic copy of the text, tables and figures to piocontieditor@yahoo.it, and it is essential that they retain a copy of the original manuscript as the Editor does not accept responsibility for loss of papers submitted. Papers are accepted on the understanding that no substantial part has been, or will be published elsewhere, and once they have been accepted they remain the copyright of the journal. Preparation of the text: Manuscripts should be in a Word file with double spacing and 30 mm margins all around. The first page should bear the title of the paper, last name(s) and initial(s) of the author(s) with their affiliation(s) and the postal address, tel. and fax numbers and e-mail address of the corresponding author. For indexing purposes a small number of key words should be supplied.Generally, papers should be divided into the following parts and in the order indicated: (1) Summary: about 5% of the length of the paper; (2) Introduction: containing the reason for doing the work; (3) Materials and Methods: sufficient information must be included to permit repetition of the experimental work; (4) Results: these should be given concisely together with tables and figures that have clear legends; (5) Discussion: the presentation of results should be separate from a discussion of their significance; the section should not repeat Results; (6) Acknowledgements if any; (7) References: these should be cited in the text by a number in parentheses and listed at the end of the paper in numerical order. Note the following style for journal and book citations:1. Autorino R, Lamendola MG, De Luca G, De Sio M, Giuliano F, D’ Armiento M, De Placido S, Conti P,

Di Lorenzo G. Neuroendocrine immunophenotype as predictor of clinical recurrence in 110 patients with prostate cancer. Int J Immunopathol Pharmacol 2007; 20:765-70.

2. Robb RJ, Lin Y. T-cell growth factor purification, interaction with a cellular receptor and in vitro synthesis. In Thymic Hormones and Lymphokines. A.L. Goldstein, ed. Plenum Publishing Corp. New York, 1984; p. 274.

Abbreviation of titles of Journals should follow the list of journals indexed in INDEX MEDICUS. References to books should include the editor(s), publisher and place of publication. Authors are responsible for the accuracy of their references.All authors are required to send a No conflict of interest statement.Illustrations: The Journal recognizes the adoption of the SI unit system. All tables and figures should be cited in order in the text, using Roman numerals for the tables and Arabic numerals for figures. Tables should have a short title. Figures can be sent on a separate PDF or jpg file bearing the first author’s name. Proof-reading: Page proofs will be submitted to the contributors for minor corrections and should be returned to the Editor within three days. Major alterations to the text cannot be accepted.Editorial correspondence: All manuscripts, letters to the Editor and any correspondence regarding Editorial matters, should be sent to the Editor-in-Chief: Dr Pio Conti, Professor of Immunology, Postgraduate Medical School, University Zone, viale Unità d’Italia 73, 66100, Chieti, Italy. Tel./Fax +39 0871 574136; e-mails: piocontieditor @yahoo.itCommercial correspondence including advertising, requests for back numbers and reprints should be sent electronically to biolife_sas@yahoo.it or to the Editor-in-Chief. Website: www.biolifesas.org